Federal Judge: Investors Cite No False Claims In Gene Therapy Securities Suit
BOSTON — A federal judge in Massachusetts dismissed a putative class complaint filed by investors against a biopharmaceutical company and certain of its executives, finding that the investors did not substantiate...To view the full article, register now.
Already a subscriber? Click here to view full article